Stay updated on RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.

Latest updates to the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page
- Check2 days agoChange DetectedAdds new release notes for v3.0.2 with recent dates and an estimated update label, and removes older July entries and the old v3.0.1 notes to focus on the current release and streamline the history.SummaryDifference0.7%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check16 days agoChange DetectedThe web page has been updated to include new drug information for omaveloxolone and additional resources related to various diseases, while some specific location details and previous genetic resources have been removed.SummaryDifference3%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe webpage has added detailed information about a new clinical study on RTA 408 (Omaveloxolone) for individuals with Friedreich's Ataxia, including study goals, methods, and timelines, while removing previous service alerts and older study references.SummaryDifference17%
Stay in the know with updates to RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.